« Back
Home /
Nivolumab

Nivolumab

Item no.	TMO-T9907-5mg
Manufacturer	TargetMol
CASRN	946414-94-4
Amount	5 mg
Quantity options	100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	946414-94-4
Shipping condition	Cool pack
Available
Manufacturer - Targets	PD-1/PD-L1
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	146 kDa
Description	Nivolumab is a monoclonal antibody, a humanized IgG4 antibody to PD-1. Nivolumab has antitumor activity and is used in the treatment of melanoma, non-small cell lung cancer, renal cell carcinoma and others.
Pathways	Apoptosis\|\|\|Immunology/Inflammation\|\|\|Cell Cycle/Checkpoint

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 1/31/2025